Letterpenny You are talking about Cytoviatx or Cytovia Therapeutics not the subsidiary of Immune Pharmaceuticals . Therefore shareholders will receive no value from any transaction involving Cytovia Therapeutics or Cytoviatx. That is fact not fantasy. Cheers Truth and Justice